Xencor: Truist Securities raises target price to $29 from $27
XNCR•Truist Securities raised its target price for Xencor to $29 from $27.
Related News
Sigma Lithium touts “Quintuple Zero” lithium oxide production at UN Climate Week New York
SGML•
IGC Pharma completes enrollment in Phase 2 CALMA Alzheimer’s agitation trial, expects topline data in Q4 2026
IGC•
Trump Jr.-backed Unusual Machines and U.S. asset manager reportedly invest $10 million in Canada's Draganfly
DPRO•
Keros doses first patient in Phase 2 rinvatercept trial for Duchenne muscular dystrophy
KROS•
H.B. Fuller names R. Jeffrey Bailly to board of directors
FUL•